Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -16,317 | -3,833 | N/A | N/A |
| Depreciation Amortization | 184 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 604 | 950 | N/A | N/A |
| Other Working Capital | 1,247 | 1,041 | N/A | N/A |
| Other Operating Activity | 2,364 | -883 | 0 | 0 |
| Operating Cash Flow | $-11,918 | $-2,725 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2,988 | N/A | N/A | N/A |
| Other Investing Activity | -314 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,302 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 80 | N/A | N/A | N/A |
| Other Financing Activity | 22,040 | 2,860 | 0 | 0 |
| Financing Cash Flow | $22,120 | $2,860 | $N/A | $N/A |
| Beginning Cash Position | 135 | N/A | N/A | N/A |
| End Cash Position | 7,035 | 135 | N/A | N/A |
| Net Cash Flow | $6,900 | $135 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -11,918 | -2,725 | N/A | N/A |
| Capital Expenditure | -2,988 | N/A | N/A | N/A |
| Free Cash Flow | -14,906 | -2,725 | 0 | 0 |